PRESS RELEASE published on 07/09/2024 at 20:45, 1 year 5 months ago Inside Information / News release on accounts, results Acticor Biotech publishes its 2023 annual results, financial highlights, and financing outlook. Annual General Meeting scheduled for September 13, 2024 Annual General Meeting Financial Highlights 2023 Annual Results ACTICOR BIOTECH Financing Outlook
PRESS RELEASE published on 07/09/2024 at 20:45, 1 year 5 months ago Informations privilégiées / Communiqué sur comptes, résultats Acticor Biotech publie ses résultats financiers annuels pour 2023, avec une perte nette de 18,640 K€. La trésorerie s'élève à 3,9 M€. L'AG se tiendra le 13 septembre 2024 Résultats Financiers Assemblée Générale Trésorerie Perte Nette ACTICOR BIOTECH
BRIEF published on 05/15/2024 at 11:20, 1 year 7 months ago Résultats de l'étude ACTISAVE et perspectives futures d'ACTICOR BIOTECH ACTICOR BIOTECH Étude ACTISAVE Traitement AVC Glenzocimab ESOC 2024
BRIEF published on 05/15/2024 at 11:20, 1 year 7 months ago Results of the ACTISAVE study and future perspectives of ACTICOR BIOTECH Stroke Treatment ACTICOR BIOTECH Glenzocimab ESOC 2024 ACTISAVE Study
PRESS RELEASE published on 05/15/2024 at 11:15, 1 year 7 months ago Informations privilégiées / Autres communiqués ACTICOR BIOTECH présente les résultats de l'étude ACTISAVE sur le traitement de l'AVC ischémique lors de l'ESOC 2024. Perspectives prometteuses pour le glenzocimab malgré l'absence d'efficacité globale ACTICOR BIOTECH Glenzocimab ESOC 2024 AVC Ischémique ACTISAVE
PRESS RELEASE published on 05/15/2024 at 11:15, 1 year 7 months ago Inside Information / Other news releases ACTICOR BIOTECH presents main results of phase 2/3 ACTISAVE study on stroke treatment at ESOC 2024, targeting specific subgroups for potential benefits Stroke Treatment ACTICOR BIOTECH ESOC 2024 ACTISAVE Study Patient Subgroups
Published on 12/18/2025 at 00:55, 2 hours 56 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 51 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 36 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 51 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 51 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 2 hours 41 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 1 minute ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 46 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 46 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 29 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 12 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 12 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 21 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 51 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
